Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Co-benefits of Co-delivery of Long-acting Antiretrovirals and Contraceptives

NCT05044962 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT05044962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05044962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Co-benefits of Co-delivery of Long-acting Antiretrovirals and Contraceptives
Lead sponsor
University of Alabama at Birmingham
Phase
Not applicable
Overall status
Recruiting
Start date
November 26, 2021
Completion date
March 31, 2027
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contraception, drug-drug interaction, hiv infections